FIELD: medicine, pharmaceutics.
SUBSTANCE: invention relates to dermatology and represents therapeutic medication for treatment of skin lesions, which contains as active ingredient substance, influencing the receptor which stimulates secretion of growth hormone, or its pharmaceutically acceptable salt, where substance represents peptide, selected from group, which consists of: (i) peptide compound with amino acid sequence, represented by any of sequences SEQ ID NO: 1-21, where amino acid residue in position 3, counting from amino end, represents modified amino acid residue, into hydroxyl group of whose side chain fatty acid is introduced; and (ii) peptide compound with amino acid sequence, represented by any of sequences SEQ ID NO: 1-21, where one or several amino acids in position 5, counting from amino end to carboxy end, are removed, substituted and/or added, the third amino acid residue, counting from amino end, represents modified amino acid residue, into whose side chain fatty acid is introduced; and (iii) GHRP-6; therapeutic medication contains active ingredient in amount from 0.001 mg to 100 mg per composition unit.
EFFECT: acceleration of healing.
28 cl, 4 ex, 4 dwg
Title | Year | Author | Number |
---|---|---|---|
STIMULATOR OF PANCREATIC BETA-CELL REGENERATION AND INSULIN PRODUCTION IN PANCREATIC BETA-CELLS | 2006 |
|
RU2403058C2 |
THERAPEUTIC AGENT FOR AMYOTROPHIC LATERAL SCLEROSIS | 2013 |
|
RU2655811C2 |
PEPTIDE ANALOGUE COMPOUNDS OF GROWTH HORMONE SECRETION STIMULANTS AND PREPARATIONS CONTAINING SAID COMPOUNDS | 2007 |
|
RU2416618C2 |
USE OF GHRELIN SPLICING VERSION FOR TREATING CACHEXIA AND/OR ANOREXIA, AND/OR ANOREXIA-CACHEXIA, AND/OR EATING DISORDER, AND/OR LIPODYSTROPHY, AND/OR MUSCLE ATROPHY, AND/OR APPETITE STIMULATION | 2007 |
|
RU2470940C2 |
CELL-PENETRATING PEPTIDES | 2010 |
|
RU2548807C2 |
CONJUGATES OF GHRELIN CARRIER | 2003 |
|
RU2325202C2 |
ANALOGUES OF GHRELIN SUBSTITUTED AT N-END | 2007 |
|
RU2459831C2 |
ANTI-AGING AND WOUND-HEALING COMPOSITIONS | 2002 |
|
RU2318873C2 |
NEW IMMUNOGENIC PEPTIDES | 2015 |
|
RU2709711C2 |
CYTOTOXICITY-INDUCING THERAPEUTIC AGENT | 2011 |
|
RU2774414C2 |
Authors
Dates
2011-06-10—Published
2006-11-21—Filed